Shots: The CE Mark approval is based on TRILUMINATE study with positive six-month data assessing edge-to-edge repair technique using TriClip and resulted in reduced severity of TR with improvement in […]readmore
Tags : Invasive
Shots: The BT designation follows the P-IIb Trial in patients with IFD or probable invasive aspergillosis (IA) and either refractory disease, resistance, or intolerance to available agents The study resulted […]readmore
Shots: The BT designation is based on P-I/II and P-II results assessing four lots of V114 in healthy adults and infants, demonstrating non-inferiority data in patients FDA’s BT designation is […]readmore